Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03789773|
Recruitment Status : Recruiting
First Posted : December 31, 2018
Last Update Posted : May 3, 2019
|Condition or disease||Intervention/treatment||Phase|
|Unspecified Adult Solid Tumor||Device: Millimeter-Wave Holographic Imaging||Not Applicable|
I. To obtain patient images in a clinical setting and assess their quality.
I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric.
Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial computed tomography (CT) simulation.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Holographic Mm-wave Imaging in Radiation Oncology|
|Actual Study Start Date :||December 14, 2018|
|Estimated Primary Completion Date :||December 14, 2020|
|Estimated Study Completion Date :||June 15, 2021|
Experimental: Diagnostic (holographic mm-wave imaging)
Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial CT simulation.
Device: Millimeter-Wave Holographic Imaging
Undergo mm-wave holographic imaging
Other Name: Holographic Millimeter-wave Imaging; Holographic mm-Wave Imaging; MMW Holographic Imaging; Millimeter-wave Imaging; MMW Imaging; MMW
- Qualitative assessment of holographic image quality [ Time Frame: Up to 1 year ]Qualitative assessment of image quality by study physicians according to the scoring of each image as: 1 = High Quality (A); 2= Acceptable Quality (B); 3 = Poor/Unacceptable Quality (C). Lower value (1) represents a better score than higher value (3). There are no subscales and or total scores. The quality scores of the images will be tabulated.
- Image registration agreement between mm-wave holographic images and a cone-beam computed tomography (CBCT)/optical surface image [ Time Frame: Up to 1 year ]The distribution of the percent of points in voxel-voxel analysis to agree to better than 2 mm will be tabulated
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789773
|United States, California|
|USC / Norris Comprehensive Cancer Center||Recruiting|
|Los Angeles, California, United States, 90033|
|Contact: Michael Reilly, PhD 708-951-1100 Michael.email@example.com|
|Principal Investigator: Michael Reilly, PhD|
|Principal Investigator:||Michael Reilly||University of Southern California|